Author name: zascorporation

ZAS Corporation Ltd. is delighted to announce the signing of a Memorandum of Understanding (MOU) with LABAID Diagnostics and LABAID Cancer Hospital & Super Speciality Centre. This strategic partnership aims to provide employees with access to comprehensive health check-ups and state-of-the-art medical facilities. By joining forces with LABAID, ZAS Corporation reinforces its dedication to fostering […]

ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland, for preventing recurrent urinary tract infections (UTIs). The launch event brought together leading healthcare professionals to discuss Uro-Vaxom’s role in boosting immune defense and reducing UTI recurrence, marking a significant milestone in UTI care. This innovative product reflects ZAS Corporation’s commitment to

In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology (NIKDU), ZAS Corporation Ltd. hosted a Virtual CME on “Induction Therapy in Immunologically High-risk vs Low-risk Kidney Transplant Recipients.” Prof. Hüseyin Koçak from Akdeniz University Hospital, Antalya, Türkiye, joined virtually, providing valuable insights into personalized approaches in kidney transplant care.

ZAS Corporation proudly participated in the prestigious MOSB Congress 2024, reaffirming its dedication to advancing oncology care in Bangladesh. The event brought together leading medical professionals, healthcare experts, and pharmaceutical innovators, providing a platform to exchange knowledge and explore the latest breakthroughs in cancer treatment. Our oncology team had the privilege of engaging with esteemed

ZAS Corporation was honored to serve as the core sponsor of the 178th World Anesthesia Day celebration, organized by the Bangladesh Society of Anaesthesiologists, Critical Care and Pain Physicians (BSA_CCPP). The event marked a significant occasion in the medical community, bringing together professionals to honor the pioneers of anesthesia, reflect on the advancements in anesthesiology,

ZAS Corporation proudly marked its 19th anniversary, celebrating nearly two decades of excellence, innovation, and growth. The milestone event saw enthusiastic participation from the entire team, who came together for a memorable photo session. These group photos, collaged and shared on social media, symbolize the unity and dedication that have been the cornerstone of the

We are thrilled to have welcomed our partners from the Morinaga Research Centre, Japan, to Bangladesh. This visit signifies a pivotal moment in our ongoing collaboration aimed at advancing development. The delegation engaged in insightful discussions on shared goals, explored opportunities for growth, and reviewed future strategies to enhance mutual success.This partnership marks another milestone

We are proud to announce that ZAS Corporation Ltd. has officially secured the trademark for our brand DECA. Registered under trademark no. 243264, this certification, effective from January 26, 2020, covers gloves for medical purposes and other products under class 10. This milestone reaffirms our commitment to delivering high-quality healthcare solutions while protecting our brand

We are delighted to announce that ZAS Corporation has successfully obtained the trademark for our brand Protimeal. Registered under trademark no. 216979, effective from November 15, 2017, this certification covers all goods under class 30. This achievement highlights our dedication to protecting the integrity of our products and ensuring that Protimeal continues to provide trusted